REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) Stock Price, Quote, News & Histor

REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) Stock Price, Quote, News & History

RVPHOTCQB

Trade with Public

$0.3521

-0.44-55.73%

At close: May 12, 5:00 PM EST

$0.5700

-0.23-28.34%

Pre-Market: 3:00 AM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest

Key Statistics

Open

$0.35

Volume / Avg.

0 / 868.73K

Day Range

- - -

52 Wk Range

0.26 - 17.98

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Reviva Pharmaceuticals Holdings Inc News

Robert F. Kennedy Jr. Wants To Take 'Clear And Decisive Action' On Psychiatric Drugs Amid 'Deprescribing' Push: Big Pharma Should Pay Attention

Robert F. Kennedy Jr. unveiled a federal initiative to curb the overuse of psychiatric medications, emphasizing deprescribing and a shift toward preventive, patient-centered mental health care.

Sweta Killa

Deal Dispatch: Amazon Buys Globalstar, Instacart Grabs Instaleap, QVC Announces Bankruptcy

Major M&A deals include: Amazon's $11.6 billion acquisition of Globalstar, OpenAI buys Hiro Finance, and AIP acquires Avanos Medical.

Caroline Ryan

What's Behind The Drop In Reviva Pharmaceuticals Stock?

Reviva Pharmaceuticals shares are tumbling Thursday after pricing a $10 million public offering of over 6 million shares at $1.50 per share.

Alex Perry

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-20.20M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

37.10M

Free Cash Flow (TTM)

-20.20M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

16.90M

Analyst Trends and Forecast

Dec 25

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$14.09M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

0.45

Earnings Yield % (TTM)

-561.31%

Earnings Yield % (FWD)

-300.04%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.33

Company Debt

Total Debt

$231.27K

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$22.19M

Debt to Equity

0.01

Issuance of Debt (TTM)

Repayment of Debt (TTM)

-$399.90K

Key Statistics

Open

$0.35

Volume / Avg.

0 / 868.73K

Day Range

- - -

52 Wk Range

0.26 - 17.98

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and ca...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock?

You can purchase shares of REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (OTCQB:RVPH) through any online brokerage.

View our list of the best stock brokerages

Who are REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) competitors?

There are no as such competitors for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc..

What is the forecast, or price target, for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock?

REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. has a consensus price target of $9.70.

What is the current price for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH)?

The stock price for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (OTCQB: RVPH) is $0.59325 last updated June 3, 2026 at 3:57 PM EDT.

Does REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) pay a dividend?

There are no upcoming dividends for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc..

When is REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (OTCQB:RVPH) reporting earnings?

REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. does not have any upcoming earnings scheduled.

Is REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) going to split?

There is no upcoming split for REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc..

What sector and industry does REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. (RVPH) operate in?

REVIVA PHARMA HLDGS INC by Reviva Pharmaceuticals Holdings, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.